MPM Oncology Innovations Fund GP LLC, 10% Owner at Werewolf Therapeutics, Inc. (HOWL), sold 419,304 shares at $0.95 ($401K) on 2025-11-17, disclosed to the SEC on 2025-11-17.
Scheduled sale ($401k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.98 | 90,951 | $89K | 22.2% |
| 2 | $0.98 | 90,951 | $89K | 22.2% |
| 3 | $0.93 | 61,640 | $57K | 14.3% |
| 4 | $0.93 | 61,640 | $57K | 14.3% |
| 5 | $0.95 | 57,061 | $54K | 13.5% |
| 6 | $0.95 | 57,061 |
| $54K |
| 13.5% |
| Total | $0.96 avg | 419,304 | $401K | 100% |
| Filing → |